ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
110 hedge funds and large institutions have $110M invested in Antares Pharma, Inc. in 2017 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 36 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
37% less capital invested
Capital invested by funds: $176M → $110M (-$65.4M)
59% less call options, than puts
Call options by funds: $46K | Put options by funds: $112K
Holders
110
Holding in Top 10
1
Calls
$46K
Puts
$112K
Top Buyers
| 1 | +$6.77M | |
| 2 | +$2.65M | |
| 3 | +$1M | |
| 4 |
TF
TIAA FSB
Jacksonville,
Florida
|
+$977K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$509K |
Top Sellers
| 1 | -$4.35M | |
| 2 | -$1.48M | |
| 3 | -$1.21M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$1.05M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$833K |